Interestingly, we found that the neutralizing antibody against ET-1 blocked breast cancer conditioned medium-induced increases in cardiomyocyte size and abolished the upregulation of the pro-hypertrophic marker, β-MHC (Fig. 3a, b, c). The gene discussed is EDN1; the disease is breast carcinoma.